US Stock MarketDetailed Quotes

MediciNova (MNOV)

Watchlist
  • 1.370
  • 0.0000.00%
Close Apr 24 16:00 ET
  • 1.370
  • 0.0000.00%
Post 20:01 ET
67.43MMarket Cap-5.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MediciNova (MNOV) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
409.66K
151.74K
123.32K
134.6K
0
0
0
0
0
0
Operating revenue
--409.66K
--151.74K
--123.32K
--134.6K
--0
--0
--0
--0
--0
--0
Cost of revenue
378.61K
146.99K
115.27K
116.35K
0
0
0
0
Gross profit
31.05K
4.75K
8.05K
18.25K
0
0
0
0
Operating expense
5.04%13.31M
-2.72%3.1M
2.42%3.39M
19.00%3.63M
2.12%3.2M
16.28%12.68M
27.85%3.18M
54.14%3.31M
-7.68%3.05M
5.83%3.14M
Selling and administrative expenses
12.38%6.16M
21.74%1.55M
24.58%1.81M
2.59%1.44M
0.63%1.36M
4.54%5.48M
52.06%1.28M
7.21%1.45M
-10.47%1.4M
-8.91%1.35M
-General and administrative expense
12.38%6.16M
21.74%1.55M
24.58%1.81M
2.59%1.44M
0.63%1.36M
4.54%5.48M
52.06%1.28M
7.21%1.45M
-10.47%1.4M
-8.91%1.35M
Research and development costs
-0.55%7.15M
-19.08%1.54M
-14.87%1.58M
32.96%2.19M
3.25%1.84M
27.16%7.19M
15.55%1.91M
133.97%1.86M
-5.17%1.65M
20.67%1.78M
Operating profit
-4.79%-13.28M
2.87%-3.09M
-2.17%-3.38M
-18.40%-3.61M
-2.12%-3.2M
-28.03%-12.68M
-27.85%-3.18M
-188.53%-3.31M
7.68%-3.05M
-5.83%-3.14M
Net non-operating interest income expense
-21.97%1.3M
-22.61%301.88K
-23.89%340.85K
-25.36%324.96K
-15.45%336.11K
-8.93%1.67M
-10.58%390.1K
2.26%447.85K
-3.56%435.35K
-21.91%397.51K
Non-operating interest income
-21.97%1.3M
-22.61%301.88K
-23.89%340.85K
-25.36%324.96K
-15.45%336.11K
-8.93%1.67M
-10.58%390.1K
2.26%447.85K
-3.56%435.35K
-21.91%397.51K
Other net income (expense)
67.70%-12.75K
62.84%-5.76K
-212.34%-10.23K
105.58%952
114.21%2.28K
92.15%-39.49K
-604.73%-15.5K
164.31%9.1K
26.52%-17.06K
96.54%-16.04K
Other non- operating income (expenses)
67.70%-12.75K
62.84%-5.76K
-212.34%-10.23K
105.58%952
114.21%2.28K
92.15%-39.49K
-604.73%-15.5K
164.31%9.1K
26.52%-17.06K
96.54%-16.04K
Income before tax
-8.58%-11.99M
0.46%-2.8M
-6.95%-3.05M
-24.85%-3.28M
-3.98%-2.86M
-28.89%-11.04M
-36.63%-2.81M
-294.43%-2.85M
8.48%-2.63M
5.59%-2.75M
Income tax
8.25%5.99K
81.72%5.54K
Net income
-8.58%-12M
0.44%-2.8M
-6.95%-3.05M
-24.85%-3.28M
-3.98%-2.86M
-28.91%-11.05M
-36.69%-2.81M
-294.43%-2.85M
8.48%-2.63M
5.59%-2.75M
Net income continuous Operations
-8.58%-12M
0.44%-2.8M
-6.95%-3.05M
-24.85%-3.28M
-3.98%-2.86M
-28.91%-11.05M
-36.69%-2.81M
-294.43%-2.85M
8.48%-2.63M
5.59%-2.75M
Minority interest income
Net income attributable to the parent company
-8.58%-12M
0.44%-2.8M
-6.95%-3.05M
-24.85%-3.28M
-3.98%-2.86M
-28.91%-11.05M
-36.69%-2.81M
-294.43%-2.85M
8.48%-2.63M
5.59%-2.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.58%-12M
0.44%-2.8M
-6.95%-3.05M
-24.85%-3.28M
-3.98%-2.86M
-28.91%-11.05M
-36.69%-2.81M
-294.43%-2.85M
8.48%-2.63M
5.59%-2.75M
Basic earnings per share
-4.35%-0.24
16.67%-0.05
0.00%-0.06
-40.00%-0.07
0.00%-0.06
-35.29%-0.23
-50.00%-0.06
-500.00%-0.06
16.67%-0.05
0.00%-0.06
Diluted earnings per share
-4.35%-0.24
16.67%-0.05
0.00%-0.06
-40.00%-0.07
0.00%-0.06
-35.29%-0.23
-50.00%-0.06
-500.00%-0.06
16.67%-0.05
0.00%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 409.66K151.74K123.32K134.6K000000
Operating revenue --409.66K--151.74K--123.32K--134.6K--0--0--0--0--0--0
Cost of revenue 378.61K146.99K115.27K116.35K0000
Gross profit 31.05K4.75K8.05K18.25K0000
Operating expense 5.04%13.31M-2.72%3.1M2.42%3.39M19.00%3.63M2.12%3.2M16.28%12.68M27.85%3.18M54.14%3.31M-7.68%3.05M5.83%3.14M
Selling and administrative expenses 12.38%6.16M21.74%1.55M24.58%1.81M2.59%1.44M0.63%1.36M4.54%5.48M52.06%1.28M7.21%1.45M-10.47%1.4M-8.91%1.35M
-General and administrative expense 12.38%6.16M21.74%1.55M24.58%1.81M2.59%1.44M0.63%1.36M4.54%5.48M52.06%1.28M7.21%1.45M-10.47%1.4M-8.91%1.35M
Research and development costs -0.55%7.15M-19.08%1.54M-14.87%1.58M32.96%2.19M3.25%1.84M27.16%7.19M15.55%1.91M133.97%1.86M-5.17%1.65M20.67%1.78M
Operating profit -4.79%-13.28M2.87%-3.09M-2.17%-3.38M-18.40%-3.61M-2.12%-3.2M-28.03%-12.68M-27.85%-3.18M-188.53%-3.31M7.68%-3.05M-5.83%-3.14M
Net non-operating interest income expense -21.97%1.3M-22.61%301.88K-23.89%340.85K-25.36%324.96K-15.45%336.11K-8.93%1.67M-10.58%390.1K2.26%447.85K-3.56%435.35K-21.91%397.51K
Non-operating interest income -21.97%1.3M-22.61%301.88K-23.89%340.85K-25.36%324.96K-15.45%336.11K-8.93%1.67M-10.58%390.1K2.26%447.85K-3.56%435.35K-21.91%397.51K
Other net income (expense) 67.70%-12.75K62.84%-5.76K-212.34%-10.23K105.58%952114.21%2.28K92.15%-39.49K-604.73%-15.5K164.31%9.1K26.52%-17.06K96.54%-16.04K
Other non- operating income (expenses) 67.70%-12.75K62.84%-5.76K-212.34%-10.23K105.58%952114.21%2.28K92.15%-39.49K-604.73%-15.5K164.31%9.1K26.52%-17.06K96.54%-16.04K
Income before tax -8.58%-11.99M0.46%-2.8M-6.95%-3.05M-24.85%-3.28M-3.98%-2.86M-28.89%-11.04M-36.63%-2.81M-294.43%-2.85M8.48%-2.63M5.59%-2.75M
Income tax 8.25%5.99K81.72%5.54K
Net income -8.58%-12M0.44%-2.8M-6.95%-3.05M-24.85%-3.28M-3.98%-2.86M-28.91%-11.05M-36.69%-2.81M-294.43%-2.85M8.48%-2.63M5.59%-2.75M
Net income continuous Operations -8.58%-12M0.44%-2.8M-6.95%-3.05M-24.85%-3.28M-3.98%-2.86M-28.91%-11.05M-36.69%-2.81M-294.43%-2.85M8.48%-2.63M5.59%-2.75M
Minority interest income
Net income attributable to the parent company -8.58%-12M0.44%-2.8M-6.95%-3.05M-24.85%-3.28M-3.98%-2.86M-28.91%-11.05M-36.69%-2.81M-294.43%-2.85M8.48%-2.63M5.59%-2.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.58%-12M0.44%-2.8M-6.95%-3.05M-24.85%-3.28M-3.98%-2.86M-28.91%-11.05M-36.69%-2.81M-294.43%-2.85M8.48%-2.63M5.59%-2.75M
Basic earnings per share -4.35%-0.2416.67%-0.050.00%-0.06-40.00%-0.070.00%-0.06-35.29%-0.23-50.00%-0.06-500.00%-0.0616.67%-0.050.00%-0.06
Diluted earnings per share -4.35%-0.2416.67%-0.050.00%-0.06-40.00%-0.070.00%-0.06-35.29%-0.23-50.00%-0.06-500.00%-0.0616.67%-0.050.00%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -